We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples

By LabMedica International staff writers
Posted on 15 Dec 2023
Print article
Image: The self-heating microfluidic devices can help detect diseases without expensive lab equipment (Photo courtesy of MIT)
Image: The self-heating microfluidic devices can help detect diseases without expensive lab equipment (Photo courtesy of MIT)

Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids. Commonly known examples include at-home Covid-19 test kits, which use basic microfluidic technology. However, more complex microfluidic applications often require chemical reactions at precise temperatures. Typically, these advanced devices are produced in clean rooms and include heating elements made of expensive materials like gold or platinum, making the manufacturing process costly and challenging to scale. Researchers have now made a breakthrough by employing 3D printing to build self-heating microfluidic devices, potentially paving the way for the creation of affordable and efficient tools that could detect various diseases.

Scientists at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) innovatively utilized multimaterial 3D printing to fabricate microfluidic devices with integrated heating elements. This development allows for precise temperature control of fluids moving through the device's microscopic channels. The method is highly customizable, enabling engineers to design microfluidics that heat fluids to specific temperatures or follow defined heating patterns in designated areas of the device. Remarkably, this cost-effective production method requires only about USD 2 worth of materials for each fully functional microfluidic device.

The dimensions of the device are comparable to a U.S. quarter, and its production is quick, taking only a few minutes. This advancement is particularly significant for remote or under-resourced areas in developing countries, where access to expensive laboratory equipment for diagnostic tests is often limited. Looking ahead, the researchers aim to incorporate magnets directly into the microfluidic devices. These embedded magnets could facilitate chemical reactions that require the sorting or aligning of particles. The researchers are also investigating alternative materials capable of achieving higher temperatures. This innovation in microfluidic technology represents a significant step towards more accessible and efficient diagnostic tools, especially in areas with limited resources.

“Clean rooms in particular, where you would usually make these devices, are incredibly expensive to build and to run,” said Luis Fernando Velásquez-García, a principal scientist in MIT’s Microsystems Technology Laboratories (MTL). “But we can make very capable self-heating microfluidic devices using additive manufacturing, and they can be made a lot faster and cheaper than with these traditional methods. This is really a way to democratize this technology.”

Related Links:
MIT

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Unit-Dose Packaging solution
HLX
New
Lab Autoclave
T-Lab Eco
New
Anti-Rubella IgG (Rubella IgG) Test
Rubella IgG AccuBind ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.